Specific active immunotherapy does not prolong survival in surgically treated patients with stage IIB malignant melanoma and may promote early recurrence.
about
Specific active immunotherapy does not prolong survival in surgically treated patients with stage IIB malignant melanoma and may promote early recurrence.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Specific active immunotherapy ...... may promote early recurrence.
@ast
Specific active immunotherapy ...... may promote early recurrence.
@en
type
label
Specific active immunotherapy ...... may promote early recurrence.
@ast
Specific active immunotherapy ...... may promote early recurrence.
@en
prefLabel
Specific active immunotherapy ...... may promote early recurrence.
@ast
Specific active immunotherapy ...... may promote early recurrence.
@en
P2093
P2860
P356
P1476
Specific active immunotherapy ...... may promote early recurrence.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1978.76
P407
P577
1978-04-01T00:00:00Z